Inside the Pathophysiological Mechanisms of Cardiometabolic Diseases: the Other Pandemic to Fight

Overview

Journal Pflugers Arch

Specialty Physiology

Date 2021 Dec 28

PMID 34961913

Citations 2

Authors

Marcelo R Choi

Affiliations

Soon will be listed here.

Citing Articles

Molecular Aspects of Cardiometabolic Diseases: From Etiopathogenesis to Potential Therapeutic Targets.

Bernatova I, Bartekova M Int J Mol Sci. 2024; 25(11).

PMID: 38892029 PMC: 11172306. DOI: 10.3390/ijms25115841.

Targeting Retinol-Binding Protein 4 (RBP4) in the Management of Cardiometabolic Diseases.

Oluwamodupe C, Adeleye A Cardiovasc Toxicol. 2023; 23(9-10):285-294.

PMID: 37587250 DOI: 10.1007/s12012-023-09803-8.

References

Aguilera-Mendez A, Boone-Villa D, Nieto-Aguilar R, Villafana-Rauda S, Saavedra Molina A, Sobrevilla J . Role of vitamins in the metabolic syndrome and cardiovascular disease. Pflugers Arch. 2021; 474(1):117-140. DOI: 10.1007/s00424-021-02619-x. View

Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A . Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection. Pflugers Arch. 2021; 474(1):83-98. DOI: 10.1007/s00424-021-02606-2. View

Hid E, Mosele J, Prince P, Fraga C, Galleano M . ( -)-Epicatechin and cardiometabolic risk factors: a focus on potential mechanisms of action. Pflugers Arch. 2021; 474(1):99-115. DOI: 10.1007/s00424-021-02640-0. View

Gunawan F, Nassif M, Partridge C, Ahmad T, Kosiborod M, Inzucchi S . Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medications. Cardiovasc Endocrinol Metab. 2020; 9(2):56-59. PMC: 7228775. DOI: 10.1097/XCE.0000000000000195. View

Khan S, Ning H, Wilkins J, Allen N, Carnethon M, Berry J . Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018; 3(4):280-287. PMC: 5875319. DOI: 10.1001/jamacardio.2018.0022. View

Kim A, Jang J, Han J . Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy. Biomed Pharmacother. 2021; 145:112463. DOI: 10.1016/j.biopha.2021.112463. View

Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H . The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. Oxid Med Cell Longev. 2021; 2021:1470380. PMC: 8019370. DOI: 10.1155/2021/1470380. View

Chen T, Ma D . Untreated Chronic Gout. N Engl J Med. 2021; 385(27):e97. DOI: 10.1056/NEJMicm2112548. View

Muhammad Z, Hashmi A . Frequency of diabetic cardiomyopathy among type-2 diabetics presenting as heart failure. J Coll Physicians Surg Pak. 2013; 23(8):538-42. DOI: 08.2013/JCPSP.538542. View

10.

Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J . Effect of Salt Substitution on Cardiovascular Events and Death. N Engl J Med. 2021; 385(12):1067-1077. DOI: 10.1056/NEJMoa2105675. View

11.

Nur S, Rath S, Ahmad V, Ahmad A, Ateeq B, Imran Khan M . Nutritive vitamins as epidrugs. Crit Rev Food Sci Nutr. 2020; 61(1):1-13. DOI: 10.1080/10408398.2020.1712674. View

12.

Roson M, Cavallero S, Della Penna S, Cao G, Gorzalczany S, Pandolfo M . Acute sodium overload produces renal tubulointerstitial inflammation in normal rats. Kidney Int. 2006; 70(8):1439-46. DOI: 10.1038/sj.ki.5001831. View

13.

Roson M, Della Penna S, Cao G, Gorzalczany S, Pandolfo M, Cerrudo C . High-sodium diet promotes a profibrogenic reaction in normal rat kidneys: effects of Tempol administration. J Nephrol. 2010; 24(1):119-27. DOI: 10.5301/jn.2010.5824. View

14.

Kouyoumdzian N, Kim G, Rudi M, Rukavina Mikusic N, Fernandez B, Choi M . Clues and new evidences in arterial hypertension: unmasking the role of the chloride anion. Pflugers Arch. 2021; 474(1):155-176. DOI: 10.1007/s00424-021-02649-5. View

15.

Stanzione R, Forte M, Cotugno M, Bianchi F, Marchitti S, Rubattu S . Relevance of stromal interaction molecule 1 (STIM1) in experimental and human stroke. Pflugers Arch. 2021; 474(1):141-153. DOI: 10.1007/s00424-021-02636-w. View

16.

Vinnakota S, Chen H . The Importance of Natriuretic Peptides in Cardiometabolic Diseases. J Endocr Soc. 2020; 4(6):bvaa052. PMC: 7278279. DOI: 10.1210/jendso/bvaa052. View

17.

Wallace D . The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene. 2005; 354:169-80. DOI: 10.1016/j.gene.2005.05.001. View

18.

Zhou B, Tian R . Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest. 2018; 128(9):3716-3726. PMC: 6118589. DOI: 10.1172/JCI120849. View